GLIKNIK INC

Profile

Company Names

GLIKNIK INC

Addresses

801 WEST BALTIMORE STREET, SUITE 501A, BALTIMORE, MD 21201

Phone Numbers

(410) 685-4259

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$50,672,737.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2025-08-15 
$11,000,000.00 
$15,000,000.00 
$4,000,000.00 
Debt 
9
2024-11-06 
$5,286,743.00 
$6,000,000.00 
$713,257.00 
Debt 
8
2023-06-29 
$9,175,302.00 
$16,200,000.00 
$7,024,698.00 
Equity, Debt 
7
2021-05-20 
$4,300,005.00 
$12,000,003.00 
$7,699,998.00 
Equity 
6
2013-09-03 
$2,835,000.00 
$5,000,000.00 
$2,165,000.00 
Equity 
5
2012-08-13 
$9,900,015.00 
$15,000,000.00 
$5,099,985.00 
Equity 
4
2011-08-24 
$2,038,552.00 
$2,328,552.00 
$290,000.00 
Equity 
3
2010-12-21 
$849,605.00 
$3,900,000.00 
$3,050,395.00 
Equity 
2
2010-08-17 
$2,400,000.00 
$4,000,000.00 
$1,600,000.00 
Equity 
1
2008-08-19 
$2,887,515.00 
$3,612,500.00 
$724,985.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
S. 
BLOCK 
EXECUTIVE OFFICER, DIRECTOR
ELIZABETH 
 
BLOCK 
EXECUTIVE OFFICER
ELIZABETH 
C. 
BLOCK 
EXECUTIVE OFFICER
ELIZABETH 
S. 
BLOCK 
EXECUTIVE OFFICER
DAVID 
 
BROSER 
DIRECTOR
PAUL 
 
FREIDMAN 
DIRECTOR
PAUL 
A. 
FRIEDMAN 
DIRECTOR
JOSEPH 
S. 
KLEIN 
DIRECTOR
JOSEPH 
 
KLEIN, III 
DIRECTOR
MARK 
A. 
LERNER 
DIRECTOR
RICHARD 
S. 
LEVY 
DIRECTOR
CHARLES 
 
POLSKY 
DIRECTOR
KYLE 
 
RUSCONI 
DIRECTOR
KYLE 
J. 
RUSCONI 
DIRECTOR
RAYMOND 
 
SCHINAZI 
DIRECTOR
RAYMOND 
F. 
SCHINAZI 
DIRECTOR
RAYMOND 
S. 
SHINAZI 
DIRECTOR
SCOTT 
 
STROME 
DIRECTOR
SCOTT 
ERIC 
STROME 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-08-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-06-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-06-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-20 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-09-03 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-08-13 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-08-13 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-08-13 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-08-24 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2010-12-21 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-08-17 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-08-17 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2008-08-19 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2008-08-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MOODY CAPITAL SOLUTIONS
FRANK GOLDMAN
TRESTLE POINT, LLC
M PARTNERS INC.
NONE
MOODY CAPITAL SOLUTIONS, INC.
NONE
NONE
MID ATLANTIC CAPITAL CORPORATION
FRANK GOLDMAN
MID ATLANTIC CAPITAL GROUP, INC.